Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on April 17, 2025
How to Choose the Best Plastic Surgeon
EIN Presswire
·
April 17, 2025
Nacogdoches plastic surgeon Dr. Gregory Wittpenn shares advice about choosing a trusted provider for safe, natural-looking cosmetic surgery results. NACOGDOCHES, TX, UNITED STATES, April 17, 2025 /EINPresswire.com/ -- Choosing the right plastic surgeon …
Autonomize AI Copilot Helps Health Plans Save up to 55% in Prior Authorization Efforts
EIN Presswire
·
April 17, 2025
Health Plans using Autonomize AI achieve significant efficiency gains, improved care quality and seamless integration into existing workflows without disruption AUSTIN, TX, UNITED STATES, April 17, 2025 /EINPresswire.com/ -- Autonomize AI, a leader in …
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
GlobeNewswire
·
April 17, 2025
CALGARY, Alberta, April 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat …
Sotera Health Announces First-Quarter 2025 Earnings Release Date
GlobeNewswire
·
April 17, 2025
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will …
Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders
GlobeNewswire
·
April 17, 2025
-- $300 million aggregate share repurchase authorization-- -- Reinforces confidence in 5x30 plan – -- Continued focus on margin expansion and operational efficiency -- BRISBANE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: …
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 17, 2025
THE WOODLANDS, TX, April 17, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system …
FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT
GlobeNewswire
·
April 17, 2025
FLORIDA, April 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today announced that its Board of Directors has approved a 1 for 10 reverse stock split of the Company’s Class A common stock, par value $0. …
Catheter Precision Makes NYSE American Section 610(b) Public Announcement
GlobeNewswire
·
April 17, 2025
Fort Mill, S.C., April 17, 2025 (GLOBE NEWSWIRE) -- -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that …
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC
GlobeNewswire
·
April 17, 2025
Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025 SAN MATEO, Calif., April 17, 2025 (GLOBE NEWSWIRE) …
Globus Medical Schedules First Quarter Earnings Release and Conference Call
GlobeNewswire
·
April 17, 2025
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 after the market close on Thursday, May 8, 2025. …
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 17, 2025
WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …
TELA Bio to Announce First Quarter 2025 Financial Results
GlobeNewswire
·
April 17, 2025
MALVERN, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report …
AVITA Medical to Announce First Quarter 2025 Financial Results
GlobeNewswire
·
April 17, 2025
VALENCIA, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound company delivering transformative solutions, today announced that it will report its first quarter 2025 financial results …
NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors
GlobeNewswire
·
April 17, 2025
NAARDEN, the Netherlands and MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 17, 2025
SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 15, 2025 it granted stock options to purchase an aggregate of 60,670 shares of common stock and 40,888 restricted stock …
Integrating Leading Voices: Psychedelic Science 2025 Unveils More Speakers for the World's Premier Psychedelic Conference in Denver this June
GlobeNewswire
·
April 17, 2025
Former Texas Governor Rick Perry; Shereef Elnahal, Former Undersecretary for Health, U.S. Dept. of Veterans Affairs; Congressman Jack Bergman; Congressman Morgan Luttrell; Javier Muniz, Former Associate Director, FDA Division of Psychiatry; Carl Hart, Ph.D …
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
GlobeNewswire
·
April 17, 2025
The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilities Formalized agreement aligns with previously announced topline forecasts WARREN, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio …
Oral Mucositis Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight
GlobeNewswire
·
April 17, 2025
New York, USA, April 17, 2025 (GLOBE NEWSWIRE) -- Oral Mucositis Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight The growth of the oral mucositis market is expected to be mainly driven by increasing incidence of cancer …
Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight
GlobeNewswire
·
April 17, 2025
New York, USA, April 17, 2025 (GLOBE NEWSWIRE) -- Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight The infusion pumps market is experiencing significant …
U.S. News & World Report Announces "Best of" 2025 Ratings for Legend Senior Living® Residences
GlobeNewswire
·
April 17, 2025
WICHITA, Kan., April 17, 2025 (GLOBE NEWSWIRE) -- U.S. News …